TL;DR: CellType is a Y Combinator Winter 2026 startup The agentic drug company. We simulate human biology., currently active with a team of 2.
The agentic drug company. We simulate human biology.
Last verified:
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
Yes. CellType was funded by Y Combinator in the Winter 2026 batch. The agentic drug company. We simulate human biology.
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
CellType was part of Y Combinator's Winter 2026 batch.
CellType has a team of 2 people according to Y Combinator's directory.
CellType is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…